Ginkgo Bioworks -CW27DNABWPreferred / convertible

13F holders, Q2 2026 (June 30)
1holders
0new positions
0sold out
$0.00avg. 13F price*

At the end of Q2 2026, 1 institutions reported holding Ginkgo Bioworks -CW27 (DNABW) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Harbor Investment Advisory, LLC ($0).

Company
Ginkgo Bioworks -CW27
CUSIP
37611X118
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2024: 28Q1 2024Q2 2024: 28Q2 2024Q3 2024: 5Q3 2024Q4 2024: 3Q4 2024Q1 2025: 3Q1 2025Q2 2025: 2Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions0$0
Exits0$0

Ownership 1 holders

Harbor Investment Advisory, LLC — No change 140 $0

"% of holder's portfolio" is DNABW's weight in each manager's 13F, not the share of Ginkgo Bioworks -CW27 the manager owns.